Preclinical studies in mice demonstrated that stimulation of β2AR in osteoblasts promotes bone vascular density and the colonization of the bone microenvironment by metastatic breast cancer cells, and that pharmacological inhibition of βAR signaling by β-blockers inhibits skeletal colonization by metastatic cancer cells. Here, ADRB2 is linked to cancer.